They proposed repeated infusions of MAGT1 mRNA-corrected autologous CD8+ and NK cells as a potential short-term therapy for XMEN patients [16]. This evidence concerns the gene CD8A and X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia.